Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (241-250 of 284) with videos related to

Pageof 29
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal modelsWei Li, Aleksandra Drelich, David R Martinez, et al.
Nature|February 16, 2007
Structural definition of a conserved neutralization epitope on HIV-1 gp120Tongqing Zhou, Ling Xu, Barna Dey, et al.
Cancer Research|November 18, 2020
Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted DrugsGregory M Cresswell, Bingbing Wang, Erin M Kischuk, et al.
Plos Pathogens|June 27, 2019
A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain IIIDan Hu, Zhongyu Zhu, Shun Li, et al.
Journal of Virology|December 28, 2005
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodiesZhongyu Zhu, Antony S Dimitrov, Katharine N Bossart, et al.
Science Translational Medicine|October 21, 2011
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challengeKatharine N Bossart, Thomas W Geisbert, Heinz Feldmann, et al.
Biomaterials|December 20, 2014
Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulationsPavan Puligujja, Shantanu S Balkundi, Lindsey M Kendrick, et al.
Cancer Cell|August 30, 2020
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based ImmunotherapiesJingwen Si, Xiangjun Shi, Shuhao Sun, et al.
Journal of Virology|August 4, 2019
Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus InfectionYanling Wu, Jing Xue, Chunyu Wang, et al.
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Pageof 29

Showing results (241-250 of 284) with videos related to

Sort By:
Pageof 29
Biorxiv : the Preprint Server for Biology|June 9, 2020
Rapid selection of a human monoclonal antibody that potently neutralizes SARS-CoV-2 in two animal modelsWei Li, Aleksandra Drelich, David R Martinez, et al.
Nature|February 16, 2007
Structural definition of a conserved neutralization epitope on HIV-1 gp120Tongqing Zhou, Ling Xu, Barna Dey, et al.
Cancer Research|November 18, 2020
Folate Receptor Beta Designates Immunosuppressive Tumor-Associated Myeloid Cells That Can Be Reprogrammed with Folate-Targeted DrugsGregory M Cresswell, Bingbing Wang, Erin M Kischuk, et al.
Plos Pathogens|June 27, 2019
A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain IIIDan Hu, Zhongyu Zhu, Shun Li, et al.
Journal of Virology|December 28, 2005
Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodiesZhongyu Zhu, Antony S Dimitrov, Katharine N Bossart, et al.
Science Translational Medicine|October 21, 2011
A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challengeKatharine N Bossart, Thomas W Geisbert, Heinz Feldmann, et al.
Biomaterials|December 20, 2014
Pharmacodynamics of long-acting folic acid-receptor targeted ritonavir-boosted atazanavir nanoformulationsPavan Puligujja, Shantanu S Balkundi, Lindsey M Kendrick, et al.
Cancer Cell|August 30, 2020
Hematopoietic Progenitor Kinase1 (HPK1) Mediates T Cell Dysfunction and Is a Druggable Target for T Cell-Based ImmunotherapiesJingwen Si, Xiangjun Shi, Shuhao Sun, et al.
Journal of Virology|August 4, 2019
Rapid Elimination of Broadly Neutralizing Antibodies Correlates with Treatment Failure in the Acute Phase of Simian-Human Immunodeficiency Virus InfectionYanling Wu, Jing Xue, Chunyu Wang, et al.
Journal of Virology|September 13, 2003
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1Aran F Labrijn, Pascal Poignard, Aarti Raja, et al.
Pageof 29